CN115141159A - Application of bis (fluorosulfonyl) imide as catalyst - Google Patents

Application of bis (fluorosulfonyl) imide as catalyst Download PDF

Info

Publication number
CN115141159A
CN115141159A CN202210754232.0A CN202210754232A CN115141159A CN 115141159 A CN115141159 A CN 115141159A CN 202210754232 A CN202210754232 A CN 202210754232A CN 115141159 A CN115141159 A CN 115141159A
Authority
CN
China
Prior art keywords
solvent
formula
compound shown
alkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210754232.0A
Other languages
Chinese (zh)
Other versions
CN115141159B (en
Inventor
董佳家
江营
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CN202210754232.0A priority Critical patent/CN115141159B/en
Publication of CN115141159A publication Critical patent/CN115141159A/en
Application granted granted Critical
Publication of CN115141159B publication Critical patent/CN115141159B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/24Nitrogen compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/54Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18Benzotriazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08Lactones or lactides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78Preparation processes
    • C08G63/82Preparation processes characterised by the catalyst used
    • C08G63/823Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78Preparation processes
    • C08G63/82Preparation processes characterised by the catalyst used
    • C08G63/87Non-metals or inter-compounds thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/06Preparatory processes
    • C08G77/08Preparatory processes characterised by the catalysts used

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses an application of bis (fluorosulfonyl) imide as a catalyst. According to the invention, the bis-fluorosulfonyl imide is used as a catalyst, so that the Friedel-Crafts reaction, esterification reaction, lactone ring-opening polymerization reaction, silyl ether polymerization reaction, carbonyl compound reduction etherification, alkynyl hydrolysis and other reactions can be effectively catalyzed, the reaction conditions are mild, and the atom economy is high.

Description

Application of bis (fluorosulfonyl) imide as catalyst
Technical Field
The invention relates to application of bis (fluorosulfonyl) imide as a catalyst.
Background
Bis (fluorosulfonyl) imide (HN (SO) 2 F) 2 ) The N-containing strong acid is a nitrogen-containing strong acid and is mainly applied to the field of lithium batteries, such as lithium bis (fluorosulfonyl) imide, imidazole ionic liquid and the like. The lithium bis (fluorosulfonyl) imide as the lithium battery electrolyte has higher thermal stability and hydrolytic stability compared with the traditional lithium hexafluorophosphate. Para-bis (fluorosulfonyl) imide (HN (SO) 2 F) 2 ) The structure is analyzed, and under the strong electron-withdrawing action of the fluorosulfonyl group, the negative charge on the N atom can beHighly delocalised by resonance dispersion over the entire O-S-N framework, and thus greatly enhanced (FSO) 2 ) 2 N - Secondly, the fluorosulfonyl group has larger steric hindrance and strong electron withdrawing effect, so that the coordination capability of the ion is greatly reduced.
The difluo-sulfonimide belongs to nitrogen-containing superacid, is a novel super strong Bronsted acid, and has the strength higher than concentrated sulfuric acid. Among known super acids, sulfuric acid, trifluoromethanesulfonic acid, fluorosulfonic acid and the like are widely used as catalysts in the synthesis of intermediates for medicines, pesticides, polymers and the like.
The application of the bis-fluorosulfonyl imide as a catalyst in organic synthesis is not found at present, mainly because the acid is not commercially produced at present, and the synthetic route is not mature. At present, a large amount of fluorosulfonic acid is generally needed to be used as a solvent in the synthesis of bis-fluorosulfonyl imide, the fluorosulfonic acid is expensive, and the synthesis cost is high, and in addition, the boiling point of fluorosulfonic acid is very close to that of bis-fluorosulfonyl imide, so that the separation and purification of products are difficult.
In the earlier research on the acidification process of potassium (or sodium) bis (fluorosulfonyl) imide, the applicant finds that bis (fluorosulfonyl) imide can be obtained by rapid and simple separation with high yield under the conditions of using concentrated sulfuric acid as acid and using sulfur dioxide as solvent at low temperature, and has the advantages of low price, simple post-treatment, easy separation and purification, and the synthetic route has the possibility of industrial production.
Disclosure of Invention
The invention aims to overcome the defect of narrow application field of the existing bis (fluorosulfonyl) imide and provides the application of the bis (fluorosulfonyl) imide as the catalyst, and the bis (fluorosulfonyl) imide can be used as the catalyst to efficiently catalyze Friedel-Crafts reaction, esterification reaction, lactone ring-opening polymerization reaction, silicon ether polymerization reaction, carbonyl compound reduction etherification, alkynyl hydrolysis and other reactions, and has the advantages of mild reaction conditions and high atom economy.
The invention provides an application of bis (fluorosulfonyl) imide as a catalyst in preparation of polylactone shown in a formula (I), which comprises the following steps:
in a solvent, under the action of bis (fluorosulfonyl) imide, carrying out polymerization reaction on a compound shown as a formula (I-A) and a compound shown as a formula (I-B) to obtain polylactone shown as a formula (I);
Figure BDA0003719207890000021
wherein n is 1 Is an integer of 1 to 7;
R 1 is C1-C16 alkyl or- (CH) 2 ) n2 -Ar,n 2 Is an integer of 1 to 6, ar is a C6-C10 aryl or R A Substituted C6-C10 aryl; r A Is halogen, C1-C6 alkyl or C1-C6 alkoxy;
m 1 is an integer of 50-200.
Preferably, n 1 Is 1,2 or 3, for example 3.
Preferably, R 1 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group.
Preferably, R 1 In, n 2 May be 1,2 or 3, for example 3.
Preferably, in Ar, said C6-C10 aryl and said R A The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably, in Ar, the R A R in substituted C6-C10 aryl A The number of substitution(s) may be 1 to 3 (e.g., 1), each R A The same or different.
Preferably, R A Wherein said halogen is fluorine, chlorine, bromine or iodine.
Preferably, R A The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, R A The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R 1 In which Ar is phenyl or R A A substituted phenyl group.
Preferably, it isThe compound shown as the formula (I-B) is
Figure BDA0003719207890000022
In the preparation of the polylactone represented by the formula (I), the amount of the bis-fluorosulfonyl imide is preferably 0.1 to 10% (e.g., 0.1%) of the molar amount of the compound represented by the formula (I-A).
In the preparation of the polylactone represented by the formula (I), the dosage ratio of the compound represented by the formula (I-A) and the compound represented by the formula (I-B) can be the dosage ratio commonly used in the reaction in the field, for example, the molar ratio of the compound represented by the formula (I-A) to the compound represented by the formula (I-B) is (50-200): 1, and is 100 for example.
In the preparation of the polylactone shown in the formula (I), the solvent can be a solvent commonly used in the reaction in the field, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; further examples include tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, etc.; and for example methylene chloride.
In the preparation of the polylactone of formula (I), the temperature of the polymerization reaction can be a temperature commonly used in the art for such reactions, such as 20 deg.C to the reflux temperature of the solvent, such as room temperature.
In the preparation of the polylactone of formula (I), the progress of the polymerization reaction is generally monitored by detection methods conventional in the art (e.g., TLC, HPLC or GC), and is generally determined as the end point of the reaction when the compound of formula (I-A) disappears. The time for the polymerization reaction is preferably 4 to 12 hours.
The invention also provides an application of the bis (fluorosulfonyl) imide as a catalyst in preparation of silicone oil shown in the formula (II), which comprises the following steps:
under the action of bis (fluorosulfonyl) imide, carrying out polymerization reaction on a compound shown as a formula (II-A) and a compound shown as a formula (II-B) to obtain silicone oil shown as a formula (II);
Figure BDA0003719207890000031
wherein R is 2 、R 3 、R 4 And R 5 Independently is a C1-C16 alkyl group or a C6-C10 aryl group;
m 2 is an integer of 50-200.
Preferably, R 2 、R 3 、R 4 Or R 5 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group (e.g., a C1-C3 alkyl group, and further, for example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group).
Preferably, R 2 、R 3 、R 4 Or R 5 In (e), the C6-C10 aryl group may be phenyl.
Preferably, R 2 、R 3 、R 4 And R 5 Independently of one another, C1-C10 alkyl, and further independently of one another, C1-C6 alkyl (for example C1-C3 alkyl, and further for example methyl, ethyl, n-propyl or isopropyl). More preferably, R 2 、R 3 、R 4 And R 5 Are each C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl, and further such as methyl.
In the preparation of the silicone oil represented by the formula (II), the bis-fluorosulfonyl imide is preferably used in an amount of 1 to 10% (e.g., 4%) by mole based on the compound represented by the formula (II-A).
In the preparation of the silicone oil represented by the formula (II), the dosage ratio of the compound represented by the formula (II-A) and the compound represented by the formula (II-B) can be the dosage ratio commonly used in the reaction in the field, for example, the molar ratio of the compound represented by the formula (II-A) to the compound represented by the formula (II-B) is (30-200): 1, and further 39.9.
In the preparation of the silicone oil shown in formula (II), the polymerization reaction may be performed in a solvent or in a solvent, and the solvent may be a solvent commonly used in the art, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent, and an alkane solvent; further examples are tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide and 1,4-dioxane, etc. Preferably, the polymerization is carried out in the absence of a solvent.
In the preparation of the silicone oil represented by the formula (II), the temperature of the polymerization reaction may be a temperature commonly used in the art for such a reaction, for example, 20 ℃ to the reflux temperature of the solvent, for example, room temperature.
In the preparation of the silicone oil of formula (II), the progress of the polymerization reaction can be monitored by detection methods conventional in the art (e.g., TLC, HPLC or GC), and is generally determined as the end point of the reaction when the compound of formula (II-A) disappears. The time for the polymerization reaction is preferably 2 to 12 hours.
The invention also provides an application of the bis (fluorosulfonyl) imide as a catalyst in preparation of a tetrazole compound shown as a formula (III), which comprises the following steps:
in a solvent, under the action of bis (fluorosulfonyl) imide, reacting a compound shown as a formula (III-A), an orthoformate compound shown as a formula (III-B) and sodium azide to obtain a tetrazole compound shown as a formula (III);
Figure BDA0003719207890000041
wherein R is 6 Is C1-C16 alkyl, C6-C10 aryl or R B Substituted C6-C10 aryl, R B Is halogen or C2-C4 alkynyl;
R 6-1 is methyl or ethyl.
Preferably, R 6 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group.
Preferably, R 6 Wherein said C6-C10 aryl and said R B The C6-C10 aryl group of the substituted C6-C10 aryl groups may independently be a phenyl group。
Preferably, R 6 In (1), the R B R in substituted C6-C10 aryl B The number of substitution(s) may be 1 to 3 (e.g., 1), each R B The same or different.
Preferably, R B The halogen may be fluorine, chlorine, bromine or iodine, for example bromine.
Preferably, R B In (e), the C2-C4 alkynyl group may be an ethynyl group.
Preferably, R is 6 Is R B Substituted phenyl radicals, R B Is halogen or ethynyl, e.g. the R 6 Is composed of
Figure BDA0003719207890000051
Figure BDA0003719207890000052
In the preparation of the tetrazole-type compound shown in the formula (III), the bis-fluorosulfonyl imide is preferably used in an amount of 1 to 10% (e.g., 5%) of the molar amount of the compound shown in the formula (III-a).
In the preparation of the tetrazole compound represented by the formula (III), the dosage ratio of the compound represented by the formula (III-a) and the orthoformate compound represented by the formula (III-B) may be a dosage ratio commonly used in such reactions in the art, for example, the molar ratio of the compound represented by the formula (III-a) to the orthoformate compound represented by the formula (III-B) is 1: (1-2), further example 1:1.2.
in the preparation of the tetrazole compound represented by the formula (III), the amount ratio of the compound represented by the formula (III-a) to the sodium azide may be an amount ratio commonly used in such reactions in the art, for example, the molar ratio of the compound represented by the formula (III-a) to the sodium azide is 1: (1-3), for example, 1:1 or 1:1.1.
in the preparation of the tetrazole compound shown in the formula (III), the solvent may be a solvent commonly used in the field such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent, and an alkane solvent; further examples of the solvent include glycerol, tetrahydrofuran, methylene chloride, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, etc.; for example, glycerol.
In the preparation of the tetrazole-based compound represented by the formula (III), the reaction temperature may be a temperature commonly used in the art for such reactions, for example, 20 ℃ to the reflux temperature of the solvent, for example, room temperature.
In the preparation of the tetrazole compound represented by the formula (III), the progress of the reaction can be monitored by a detection method (such as TLC, HPLC or GC) which is conventional in the art, and the end point of the reaction is generally determined when the compound represented by the formula (III-a) disappears. The reaction time is preferably 2 to 12 hours.
The invention also provides an application of the bis (fluorosulfonyl) imide as a catalyst in preparation of a compound shown as a formula (IV), which comprises the following steps:
in Sup>A solvent, under the action of bis (fluorosulfonyl) imide, carrying out addition reaction on Sup>A compound shown as Sup>A formulSup>A (IV-A) and Sup>A compound shown as Sup>A formulSup>A (IV-B) to obtain Sup>A compound shown as Sup>A formulSup>A (IV);
Figure BDA0003719207890000061
wherein the content of the first and second substances,
x is NH, S or O;
R 7 、R 8 and R 9 Independently is C1-C16 alkyl, C6-C10 aryl, R C Substituted C6-C10 aryl or
Figure BDA0003719207890000062
R C Is halogen, C1-C6 alkyl or C1-C6 alkoxy.
Preferably, R 7 、R 8 Or R 9 The C1-C16 alkyl group is, for example, C1-C10 alkyl, and further, for example, C1-C6 alkyl (for example, C1-C3 alkyl, further, for example, methyl, ethyl, n-propyl orIsopropyl).
Preferably, R 7 、R 8 Or R 9 Wherein said C6-C10 aryl and said R C The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably, R 7 、R 8 Or R 9 In (1), the R C R in substituted benzyl C The number of substitution(s) may be 1 to 3 (e.g., 1), each R C The same or different.
Preferably, R C Wherein said halogen is fluorine, chlorine, bromine or iodine.
Preferably, R C The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, R C The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R 7 And R 8 Independently C1-C16 alkyl, for example C1-C10 alkyl, and further for example C1-C6 alkyl (for example C1-C3 alkyl, further for example methyl, ethyl, n-propyl or isopropyl).
Preferably, R 9 Is composed of
Figure BDA0003719207890000063
Preferably, X is NH.
Preferably, the compound shown in the formulSup>A (IV-A) is
Figure BDA0003719207890000064
Preferably, the compound shown in the formula (IV-B) is
Figure BDA0003719207890000065
In the preparation of the compound represented by the formulSup>A (IV), the bis-fluorosulfonyl imide is preferably used in an amount of 1 to 10% (e.g., 5%) based on the molar amount of the compound represented by the formulSup>A (IV-A).
In the preparation of the compound shown in the formulSup>A (IV), the dosage ratio of the compound shown in the formulSup>A (IV-A) and the compound shown in the formulSup>A (IV-B) can be the dosage ratio commonly used in the reaction in the field, for example, the molar ratio of the compound shown in the formulSup>A (IV-A) and the compound shown in the formulSup>A (IV-B) is 1 (1-10), and further, for example, 1:1.
In the preparation of the compound represented by the formula (IV), the solvent may be a solvent commonly used in the art for such reactions, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic solvent, an amide solvent, a halogenated alkane solvent, and an alkane solvent; further examples are tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, and the like, further examples are acetonitrile.
In the preparation of the compound represented by the formula (IV), the temperature of the addition reaction may be a temperature commonly used in the art for such a reaction, for example, 20 ℃ to the reflux temperature of the solvent, for example, room temperature.
In the preparation of the compound represented by the formulSup>A (IV), the progress of the addition reaction can be monitored by Sup>A detection method (such as TLC, HPLC or GC) which is conventional in the art, and the progress is generally determined as an end point of the reaction when the compound represented by the formulSup>A (IV-A) disappears. The time of the addition reaction is preferably 10 minutes to 12 hours, for example 0.5 hour.
The invention also provides an application of the bis (fluorosulfonyl) imide as a catalyst in preparation of a compound shown as a formula (V), which comprises the following steps:
in Sup>A solvent, under the action of bis (fluorosulfonyl) imide, carrying out Friedel-crafts reaction on Sup>A compound shown as Sup>A formulSup>A (V-A) and Sup>A compound shown as Sup>A formulSup>A (V-B) to obtain Sup>A compound shown as Sup>A formulSup>A (V);
Figure BDA0003719207890000071
wherein Y is halogen,
Figure BDA0003719207890000072
R 10 Is C1-C16 alkyl, benzyl, C6-C10 aryl, R D Substituted C6-C10 aryl or R E Substituted benzyl, R D And R E Independently halogen, C1-C6 alkyl or C1-C6 alkoxy;
R 11 is C1-C6 alkyl or C1-C6 alkoxy.
Preferably, in Y, the halogen is fluorine, chlorine, bromine or iodine, for example chlorine, bromine or iodine.
Preferably, R 10 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group (for example, a C1-C3 alkyl group, and further, for example, a methyl group, an ethyl group, a n-propyl group or an isopropyl group).
Preferably, R 10 Wherein said C6-C10 aryl group and said R D The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably, R 10 In (1), the R D R in substituted C6-C10 aryl D The number of substitutions (C) may be 1 to 3 (e.g. 1), each R D The same or different.
Preferably, R 10 In (1), the R E R in substituted benzyl E The number of substitution(s) may be 1 to 3 (e.g., 1), each R E The same or different.
Preferably, R D Or R E Wherein said halogen is fluorine, chlorine, bromine or iodine.
Preferably, R D 、R E Or R 11 The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, R D 、R E Or R 11 The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R D 、R E And R 11 Independently a C1-C6 alkoxy group.
Preferably, Y is
Figure BDA0003719207890000081
Preferably, R 10 Is benzyl, phenyl, R D Substituted phenyl or R E Substituted benzyl, R D And R E Independently is a C1-C6 alkoxy group.
Preferably, the compound represented by the formulSup>A (V-A) is
Figure BDA0003719207890000082
Preferably, the compound represented by the formula (V-B) is
Figure BDA0003719207890000083
In the preparation of the compound represented by the formula (V), the bis-fluorosulfonyl imide is preferably used in an amount of 0.1 to 10% (e.g., 5%) by mole based on the compound represented by the formula (V-B).
In the preparation of the compound shown in the formulSup>A (V), the dosage ratio of the compound shown in the formulSup>A (V-A) and the compound shown in the formulSup>A (V-B) can be the dosage ratio commonly used in the reaction in the field, for example, the molar ratio of the compound shown in the formulSup>A (V-A) and the compound shown in the formulSup>A (V-B) is (1-10): 1, and further, for example, 1:1.
In the preparation of the compound shown in the formula (V), the solvent may be a solvent commonly used in the reaction in the field, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; further examples are dichloromethane, tetrahydrofuran, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, and the like, further examples are dichloromethane.
In the preparation of the compound represented by the formula (V), the temperature of the friedel-crafts reaction may be a temperature commonly used in the art for such reactions, for example, 20 ℃ to the reflux temperature of the solvent, for example, room temperature.
In the preparation of the compound of formula (V), the progress of the friedel-crafts reaction can be monitored by detection methods conventional in the art (e.g. TLC, HPLC or GC), and the end point of the reaction is generally determined when the compound of formula (V-B) disappears. The time of the Friedel-crafts reaction is preferably between 5 minutes and 12 hours, for example 0.5 hours.
The invention also provides an application of the bis (fluorosulfonyl) imide as a catalyst in preparation of a compound shown as a formula (VI), which comprises the following steps:
in a solvent, under the action of bis (fluorosulfonyl) imide, performing hydrolysis reaction on a compound shown as a formula (VI-A) and water to obtain a compound shown as a formula (VI);
Figure BDA0003719207890000091
wherein R is 12 Is C1-C16 alkyl, C6-C10 aryl or R F Substituted C6-C10 aryl, R F Is an amino group.
Preferably, R 12 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group (for example, a C1-C3 alkyl group, and further, for example, a methyl group, an ethyl group, a n-propyl group or an isopropyl group).
Preferably, R 12 Wherein said C6-C10 aryl and said R F The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably, R 12 In (1), the R F R in substituted C6-C10 aryl F The number of substitution(s) may be 1 to 3 (e.g., 1), each R F The same or different.
Preferably, R 12 Is phenyl or phenyl substituted by amino.
In the preparation of the compound represented by the formula (VI), the bis-fluorosulfonyl imide is preferably used in an amount of 5 to 30% (e.g., 10%) by mole based on the compound represented by the formula (VI-A).
In the preparation of the compound represented by the formula (VI), the amount ratio of the compound represented by the formula (VI-A) to water can be the amount ratio commonly used in the reaction in the field, for example, the molar ratio of the compound represented by the formula (VI-A) to water is 1 (1-10), and further 1.9.
In the preparation of the compound shown in the formula (VI), the solvent may be a solvent commonly used in the reaction in the field, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent, and an alkane solvent; further examples are methylene chloride, tetrahydrofuran, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, etc., further examples are 1,4-dioxane.
In the preparation of the compound represented by the formula (VI), the temperature of the hydrolysis reaction may be a temperature commonly used in the art for such a reaction, for example, 20 ℃ to the reflux temperature of the solvent, for example, 100 ℃.
In the preparation of the compound represented by the formula (VI), the progress of the hydrolysis reaction can be monitored by detection methods conventional in the art (such as TLC, HPLC or GC), and is generally determined as the end point of the reaction when the compound represented by the formula (VI-A) disappears. The time of the hydrolysis reaction is preferably 2 to 12 hours, for example 8 hours.
The invention also provides an application of the bis (fluorosulfonyl) imide as a catalyst in preparation of a compound shown as a formula (VII), which comprises the following steps:
in a solvent, under the action of bis (fluorosulfonyl) imide, reacting a compound shown as a formula (VII-A) with allyl trimethylsilane to obtain a compound shown as a formula (VII);
Figure BDA0003719207890000101
wherein R is 13 And R 14 Independently is C1-C16 alkyl, C6-C10 aryl or R G Substituted C6-C10 aryl, R G Is halogen, C1-C6 alkyl or C1-C6 alkoxy.
Preferably, R 13 Or R 14 The C1-C16 alkyl group is, for example, C1-C10 alkyl, and further, for example, C1-C6 alkyl (for example, C1-C3 alkyl, further, for example, methyl, ethyl, n-propyl orIsopropyl).
Preferably, R 13 Or R 14 Wherein said C6-C10 aryl group and said R G The C6-C10 aryl group of the substituted C6-C10 aryl group is independently a phenyl group.
Preferably, R G In (b), the halogen is fluorine, chlorine, bromine or iodine, for example chlorine.
Preferably, R G The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, R G The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R 13 Or R 14 In (1), the R G R in substituted C6-C10 aryl G The number of substitution(s) may be 1 to 3 (e.g., 1), each R G The same or different.
Preferably, R 13 And R 14 Independently is phenyl or R G Substituted phenyl radicals, R G Is C1-C3 alkoxy.
Preferably, the compound shown in the formula (VII-A) is
Figure BDA0003719207890000102
In the preparation of the compound shown in the formula (VII), the usage amount of the bis-fluorosulfonyl imide is preferably 5-30%, for example 10% of the molar amount of the compound shown in the formula (VII-A).
In the preparation of the compound represented by the formula (VII), the amount ratio of the compound represented by the formula (VII-A) and the allyltrimethylsilane may be the amount ratio commonly used in such reactions in the art, for example, the molar ratio of the compound represented by the formula (VII-A) and the allyltrimethylsilane is 1 (1-10), for example, 1.2.
In the preparation of the compound shown in the formula (VII), the solvent may be a solvent commonly used in the reaction in the field, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent, and an alkane solvent; further examples are dichloromethane, tetrahydrofuran, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, and the like, further examples are dichloromethane.
In the preparation of the compound represented by the formula (VII), the temperature of the reaction may be a temperature commonly used in the art for such a reaction, for example, -20 ℃ to room temperature, for example, room temperature.
In the preparation of the compound represented by the formula (VII), the progress of the reaction can be monitored by detection methods generally used in the art (such as TLC, HPLC or GC), and the end point of the reaction is generally defined as the time when the compound represented by the formula (VII-A) disappears. The reaction time is preferably 2 to 12 hours, for example 2 hours.
The invention also provides an application of the bis (fluorosulfonyl) imide as a catalyst in preparation of a compound shown as a formula (VIII), which comprises the following steps:
under the action of bis (fluorosulfonyl) imide, reacting a compound shown as a formula (VIII-A), a compound shown as a formula (VIII-B) and a compound shown as a formula (VIII-C) to obtain a compound shown as a formula (VIII);
Figure BDA0003719207890000111
wherein R is 15 、R 16 、R 17 、R 18 、R 19 And R 20 Independently is H, C-C16 alkyl, C6-C10 aryl or R H Substituted C6-C10 aryl, R H Is halogen, C1-C6 alkyl or C1-C6 alkoxy.
Preferably, R 15 、R 16 、R 17 、R 18 、R 19 Or R 20 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group (for example, a C1-C3 alkyl group, and further, for example, a methyl group, an ethyl group, a n-propyl group or an isopropyl group).
Preferably, R 15 、R 16 、R 17 、R 18 、R 19 Or R 20 Wherein said C6-C10 aryl and said R H The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably, R H In (b), the halogen is fluorine, chlorine, bromine or iodine, for example chlorine.
Preferably, R H The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, R H The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R 15 、R 16 、R 17 、R 18 、R 19 Or R 20 In (1), the R H R in substituted C6-C10 aryl H The number of substitution(s) may be 1 to 3 (e.g., 1), each R H The same or different.
Preferably, R 15 、R 16 、R 17 、R 18 、R 19 And R 20 Independently H, C-C6 alkyl, phenyl or R H Substituted phenyl radicals, R H Is halogen, C1-C3 alkyl or C1-C3 alkoxy.
Preferably, the compound shown in the formula (VIII-A) is
Figure BDA0003719207890000121
Preferably, the compound represented by the formula (VIII-B) is
Figure BDA0003719207890000122
Preferably, the compound represented by the formula (VIII-C) is
Figure BDA0003719207890000123
In the preparation of the compound shown in formula (VIII), the amount of the bis-fluorosulfonyl imide used is preferably 1% to 100%, for example 10% to 50%, and further for example 30% of the molar amount of the compound shown in formula (VIII-B).
In the preparation of the compound represented by the formula (VIII), the amount ratio of the compound represented by the formula (VIII-A) to the compound represented by the formula (VIII-B) can be the amount ratio commonly used in such reactions in the field, for example, the molar ratio of the compound represented by the formula (VII-A) to the compound represented by the formula (VIII-B) is (1-2): 1, for example, 1.1 or 1.3.
In the preparation of the compound represented by the formula (VIII), the amount ratio of the compound represented by the formula (VIII-A) to the compound represented by the formula (VIII-C) may be an amount ratio commonly used in such reactions in the art, for example, the molar ratio of the compound represented by the formula (VII-A) to the compound represented by the formula (VIII-C) is 1: (1-3), for example 1.3, 1.8 or 1:2.
In the preparation of the compound represented by the formula (VIII), the reaction may be carried out in the absence of a solvent or in a solvent, and the solvent may be a solvent commonly used in the art for such a reaction, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent, and an alkane solvent; further examples are tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, etc. Preferably, the reaction is carried out in the absence of a solvent.
In the preparation of the compound represented by the formula (VIII), the reaction temperature may be a temperature commonly used in the art for such a reaction, for example, room temperature to 50 ℃, for example, room temperature.
In the preparation of the compound represented by the formula (VIII), the progress of the reaction can be monitored by a detection method (such as TLC, HPLC or GC) which is conventional in the art, and the end point of the reaction is generally determined when the compound represented by the formula (VIII-B) disappears. The reaction time is preferably 2 to 12 hours.
The invention also provides an application of the bis (fluorosulfonyl) imide as a catalyst in a rearrangement reaction of a compound shown as a formula (IX), which comprises the following steps:
in a solvent, carrying out rearrangement reaction on the compound shown in the formula (IX) under the action of bis (fluorosulfonyl) imide to obtain the compound shown in the formula (IX-A) and/or the compound shown in the formula (IX-B);
Figure BDA0003719207890000131
wherein R is 21 Is C1-C16 alkyl, C6-C10 aryl or R I Substituted C6-C10 aryl, R I Is halogen, C1-C6 alkyl or C1-C6 alkoxy.
Preferably, R 21 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group (for example, a C1-C3 alkyl group, and further, for example, a methyl group, an ethyl group, a n-propyl group or an isopropyl group).
Preferably, R 21 Wherein said C6-C10 aryl and said R I The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably, R I In (b), the halogen is fluorine, chlorine, bromine or iodine, for example chlorine.
Preferably, R I The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, R I The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R 21 In (1), the R I R in substituted C6-C10 aryl I The number of substitutions (C) may be 1 to 3 (e.g. 1), each R I The same or different.
Preferably, R 21 C1-C10 alkyl, and further for example C1-C6 alkyl (for example C1-C3 alkyl, and further for example methyl, ethyl, n-propyl or isopropyl).
In the rearrangement reaction of the compound represented by the formula (IX), the bis-fluorosulfonyl imide is preferably used in an amount of 20 to 150%, for example 100 to 150%, and further for example 123% or 124% of the molar amount of the compound represented by the formula (IX).
In the rearrangement reaction of the compound represented by the formula (IX), the rearrangement reaction may be performed in no solvent or in a solvent, and the solvent may be a solvent commonly used in the art, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent, and an alkane solvent; further examples are tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, etc. Preferably, the rearrangement reaction is carried out in the absence of a solvent.
In the rearrangement reaction of the compound represented by the formula (IX), the temperature of the rearrangement reaction may be a temperature commonly used in such reactions in the art, for example, 20 ℃ to 150 ℃, for example, room temperature, 60 ℃.
In the rearrangement reaction of the compound represented by the formula (IX), the progress of the rearrangement reaction can be monitored by a detection method (such as TLC, HPLC or GC) which is conventional in the art, and the end point of the reaction is generally determined when the compound represented by the formula (IX) disappears. The time for the rearrangement reaction is preferably 2 to 12 hours, for example 3 hours.
The invention also provides an application of the bis (fluorosulfonyl) imide as a catalyst in preparation of a compound shown as the formula (X), which comprises the following steps:
under the action of bis (fluorosulfonyl) imide, reacting a compound shown as a formula (X-A) with a compound shown as a formula (X-B) to obtain a compound shown as a formula (X);
Figure BDA0003719207890000141
wherein R is 22 Is H, C-C16 alkyl, C6-C10 aryl or R J Substituted C6-C10 aryl; r is 23 Is C1-C16 alkyl, C6-C10 aryl or R K Substituted C6-C10 aryl, R J And R K Independently halogen, C1-C6 alkyl or C1-C6 alkoxy.
Preferably, R 22 Or R 23 In (A), the C1-C16 alkyl is, for example, C1-C10 alkyl, further for example C1-C6 alkyl (e.g. C1-C3 alkyl, further for example methyl)Alkyl, ethyl, n-propyl or isopropyl).
Preferably, R 22 Or R 23 Wherein said C6-C10 aryl, said R J Substituted C6-C10 aryl and said R K The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably, R J Or R K In (b), the halogen is fluorine, chlorine, bromine or iodine, for example chlorine.
Preferably, R J Or R K The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, R J Or R K The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R 22 In (1), the R J R in substituted C6-C10 aryl J The number of substitutions (c) may be 1 to 3 (e.g. 1), each R J The same or different.
Preferably, R 23 In (1), the R K R in substituted C6-C10 aryl K The number of substitution(s) may be 1 to 3 (e.g., 1), each R K The same or different.
Preferably, R 22 Is phenyl or R J A substituted phenyl group.
Preferably, R 23 Is C1-C16 alkyl, for example C1-C10 alkyl, and further for example C1-C6 alkyl (for example C1-C3 alkyl, further for example methyl, ethyl, n-propyl or isopropyl).
In the preparation of the compound shown in the formula (X), the amount of the bis-fluorosulfonyl imide used is preferably 0.1 to 10%, for example 10%, of the molar amount of the compound shown in the formula (X-a).
In the preparation of the compound represented by the formula (X), the dosage ratio of the compound represented by the formula (X-A) and the compound represented by the formula (X-B) can be the dosage ratio commonly used in the reaction in the field, for example, the molar ratio of the compound represented by the formula (X-A) to the compound represented by the formula (X-B) is 1 (1-10), for example, 1.
In the preparation of the compound represented by the formula (X), the reaction may be carried out in a solvent or in a solvent, and the solvent may be a solvent commonly used in the art for such a reaction, for example, one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic solvent, an amide solvent, a halogenated alkane solvent, and an alkane solvent; further examples are toluene, tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethylsulfoxide, N, N-dimethylformamide, 1,4-dioxane, and the like, further examples are toluene. Preferably, the reaction is carried out in the absence of a solvent.
In the preparation of the compound represented by the formula (X), the temperature of the reaction may be a temperature commonly used in the art for such a reaction, for example, room temperature — the reflux temperature of the solvent used, for example, 85 ℃.
In the preparation of the compound represented by the formula (X), the progress of the reaction can be monitored by a detection method (such as TLC, HPLC or GC) which is conventional in the art, and the end point of the reaction is generally determined when the compound represented by the formula (X-A) disappears. The reaction time is preferably 2 to 12 hours, for example 12 hours.
The invention also provides an application of the bis-fluorosulfonyl imide as a catalyst in the reduction etherification reaction of the carbonyl compound shown in the formula (XI-A), which comprises the following steps:
in a solvent, under the action of bis (fluorosulfonyl) imide and a silane compound shown in a formula (XI-B), a carbonyl compound shown in a formula (XI-A) is subjected to reduction etherification reaction to prepare a compound shown in a formula (XI);
Figure BDA0003719207890000161
wherein R is 24 And R 25 Independently is H, C-C16 alkyl, C6-C10 aryl or R L Substituted C6-C10 aryl, R L Is halogen, C1-C6 alkyl or C1-C6 alkoxy; r 24-1 Is C1-C3 alkyl.
Preferably, R 24 Or R 25 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group (for example, a C1-C3 alkyl group, and further, for example, a methyl group, an ethyl group, a n-propyl group or an isopropyl group).
Preferably, R 24 Or R 25 Wherein said C6-C10 aryl and said R L The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably, R L In (b), the halogen is fluorine, chlorine, bromine or iodine, for example chlorine.
Preferably, R L The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, R L The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R 24 Or R 25 In (1), the R L R in substituted C6-C10 aryl L The number of substitution(s) may be 1 to 3 (e.g., 1), each R L The same or different.
Preferably, R 24 And R 25 Independently is H, phenyl or R L A substituted phenyl group.
Preferably, R 24-1 Is methyl, ethyl, n-propyl or isopropyl.
Preferably, the carbonyl compound represented by the formula (XI-A) is
Figure BDA0003719207890000162
Figure BDA0003719207890000163
In the reductive etherification reaction of the carbonyl compound represented by the formula (XI-A), the amount of the bis-fluorosulfonyl imide is preferably 0.1 to 10%, for example 0.1 to 5%, and further for example 1%, of the molar amount of the carbonyl compound represented by the formula (XI-A).
In the reductive etherification reaction of the carbonyl compound shown in the formula (XI-A), the amount of the silane compound shown in the formula (XI-B) can be the amount commonly used in such reactions in the art, for example, the molar ratio of the carbonyl compound shown in the formula (XI-A) to the silane compound shown in the formula (XI-B) is 1 (1-2), for example, 1.
In the reductive etherification reaction of the carbonyl compound represented by the formula (XI-a), the solvent may be a solvent commonly used in such reactions in the art, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent, and an alkane solvent; further examples are tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, and the like, such as dichloromethane.
In the reductive etherification reaction of the carbonyl compound represented by the formula (XI-a), the temperature of the reductive etherification reaction may be a temperature commonly used in such reactions in the art, for example, 0 ℃ to room temperature, for example, room temperature.
In the reductive etherification reaction of the carbonyl compound represented by the formula (XI-A), the progress of the reductive etherification reaction can be monitored by a detection method (such as TLC, HPLC or GC) which is conventional in the art, and the progress is generally used as the end point of the reaction when the carbonyl compound represented by the formula (XI-A) disappears. The time for the reductive etherification reaction is preferably 5 minutes to 12 hours, for example, 0.5 hour, 1 hour.
The invention also provides a preparation method of the silicon ester bis (fluorosulfonyl) imide shown in the formula (XII), which comprises the following steps:
reacting the compound shown in the formula (XII-A) with bis (fluorosulfonyl) imide to obtain bis (fluorosulfonyl) imide acid silicone ester shown in the formula (XII);
Figure BDA0003719207890000171
wherein Z is H, halogen, C1-C16 alkyl, C6-C10 aryl or R N Substituted C6-C10 aryl, R 26 、R 27 And R 28 Independently is C1-C16 alkyl, C6-C10 aryl, R M Substituted C6-C10 aryl or
Figure BDA0003719207890000172
R 29 、R 30 And R 31 Independently is C1-C6 alkyl, R M And R N Independently halogen, C1-C6 alkyl or C1-C6 alkoxy.
Preferably Z, R 26 、R 27 Or R 28 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group (for example, a C1-C3 alkyl group, and further, for example, a methyl group, an ethyl group, a n-propyl group or an isopropyl group).
Preferably Z, R 26 、R 27 Or R 28 Wherein said C6-C10 aryl, said R N Substituted C6-C10 aryl and said R M The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably Z, R M Or R N In (b), the halogen is fluorine, chlorine, bromine or iodine, for example chlorine.
Preferably, R M Or R N The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, R M Or R N The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R 26 、R 27 Or R 28 In (1), the R M R in substituted C6-C10 aryl M The number of substitutions (C) may be 1 to 3 (e.g. 1), each R M The same or different.
Preferably, R 29 、R 30 Or R 31 The C1-C6 alkyl group is a C1-C3 alkyl group such as methyl, ethyl, n-propyl or isopropyl.
Preferably, in Z, the R N R in substituted C6-C10 aryl N The number of substitution(s) may be 1 to 3 (e.g., 1), each R N The same or different.
Preferably, R 26 、R 27 And R 28 Independently is
Figure BDA0003719207890000181
R 29 、R 30 And R 31 Independently a C1-C3 alkyl group (e.g., methyl, ethyl, n-propyl, or isopropyl).
Preferably, Z is H or halogen, more preferably, Z is H.
Preferably, the compound shown in the formula (XII-A) is
Figure BDA0003719207890000182
In the preparation method of the silicon bis (fluorosulfonyl) imide acid ester shown in the formula (XII), the dosage ratio of the compound shown in the formula (XII-a) and the bis (fluorosulfonyl) imide can be the dosage ratio commonly used in such reactions in the field, for example, the molar ratio of the compound shown in the formula (XII-a) to the bis (fluorosulfonyl) imide is (1-10): 1, for example 1:1.
In the preparation method of the silicon bis (fluorosulfonyl) imide ester shown in the formula (XII), the reaction can be carried out in no solvent or in a solvent, and the solvent can be a solvent commonly used in the reaction in the field, such as one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; further examples are tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethylsulfoxide, N, N-dimethylformamide, 1,4-dioxane, and the like, further examples are acetonitrile or dichloromethane. Preferably, the reaction is carried out in the absence of a solvent.
In the method for preparing the silicon bis (fluorosulfonyl) imide ester represented by the formula (XII), the reaction temperature may be a temperature commonly used in the art for such a reaction, for example, 0 ℃ to room temperature, for example, room temperature.
In the preparation method of the silicon bis (fluorosulfonyl) imide ester shown in the formula (XII), the progress of the reaction can be monitored by a detection method (such as TLC, HPLC, or GC or NMR) which is conventional in the art, and the end point of the reaction is generally determined when bis (fluorosulfonyl) imide disappears. The reaction time is preferably 30 minutes to 2 hours, for example 1 hour.
The invention also provides an application of the bis-fluorosulfonyl imide in preparation of a compound shown as a formula (XIII) as a catalyst, which comprises the following steps:
under the action of difluoride sulfimide, reacting a compound shown as a formula (XIII-A), a compound shown as a formula (XIII-B) and a compound shown as a formula (XIII-C) to obtain a compound shown as a formula (XIII);
Figure BDA0003719207890000191
wherein Q is CH or N;
R 32 is halogen, C1-C16 alkyl, C6-C10 aryl or R O Substituted C6-C10 aryl;
m 3 is 0, 1,2, 3 or 4;
R 33 is C1-C16 alkyl, C6-C10 aryl or R P Substituted C6-C10 aryl;
R O and R P Independently halogen, C1-C6 alkyl or C1-C6 alkoxy.
Preferably, m 3 Is 0 or 1 (e.g. m) 3 Is 0).
Preferably, Q is N.
Preferably, R 32 In (b), the halogen is fluorine, chlorine, bromine or iodine, for example chlorine.
Preferably, R 32 Or R 33 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group (for example, a C1-C3 alkyl group, and further, for example, a methyl group, an ethyl group, a n-propyl group or an isopropyl group).
Preferably, R 32 Or R 33 Wherein said C6-C10 aryl, said R O Substituted C6-C10 aryl and said R P The C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl.
Preferably, R O Or R P In (b), the halogen is fluorine, chlorine, bromine or iodine, for example chlorine.
Preferably, R O Or R P Wherein said C1-C6 alkyl is C1-C3 alkyl, for exampleMethyl, ethyl, n-propyl or isopropyl.
Preferably, R O Or R P The C1-C6 alkoxy group is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy.
Preferably, R 32 In (1), the R O R in substituted C6-C10 aryl O The number of substitutions (C) may be 1 to 3 (e.g. 1), each R O The same or different.
Preferably, R 33 In (1), the R P R in substituted C6-C10 aryl P The number of substitution(s) may be 1 to 3 (e.g., 1), each R P The same or different.
Preferably, R 33 C1-C6 alkyl, for example C1-C3 alkyl, and further for example methyl, ethyl, n-propyl or isopropyl.
In the preparation of the compound shown in the formula (XIII), the bis-fluorosulfonyl imide is preferably used in an amount of 5 to 20 mol%, for example 10 mol%, based on the compound shown in the formula (XIII-B).
In the preparation of the compound represented by the formula (XIII), the amount ratio of the compound represented by the formula (XIII-A) to the compound represented by the formula (XIII-B) may be an amount ratio commonly used in such reactions in the art, for example, the molar ratio of the compound represented by the formula (XIII-A) to the compound represented by the formula (XIII-B) is (1-2): 1, for example, 1.1.
In the preparation of the compound represented by the formula (XIII), the amount ratio of the compound represented by the formula (XIII-C) to the compound represented by the formula (XIII-B) may be an amount ratio commonly used in such reactions in the art, for example, the molar ratio of the compound represented by the formula (XIII-C) to the compound represented by the formula (XIII-B) is (1-200): 1, for example 192.5:1.
in the preparation of the compound represented by the formula (XIII), the reaction can be carried out in no solvent or in a solvent, and the solvent can be one or more of solvents commonly used in the reaction in the field, such as sulfoxide solvents, ketone solvents, alcohol solvents, ether solvents, ester solvents, aromatic hydrocarbon solvents, amide solvents, halogenated alkane solvents and alkane solvents; further examples are tetrahydrofuran, dichloromethane, ethyl acetate, dimethyl sulfoxide, N, N-dimethylformamide, 1,4-dioxane, etc., further examples are acetonitrile or dichloromethane. Preferably, the reaction is carried out in the absence of a solvent.
In the preparation of the compound represented by the formula (XIII), the reaction temperature may be a temperature commonly used in the art for such reactions, for example, 50 ℃ to 120 ℃, and further for example, 60 ℃.
In the preparation of the compound of formula (XIII), the progress of the reaction is generally monitored by detection methods conventional in the art (e.g., TLC, HPLC or GC or NMR), and the end point of the reaction is generally determined as the time at which the compound of formula (XIII-B) disappears. The reaction time is preferably 1 to 5 hours, for example 3.5 hours.
In the present invention, room temperature means 20 ℃ to 30 ℃.
Unless otherwise defined, the terms used in the present invention have the following meanings:
the term "alkyl" refers to a straight or branched chain alkyl group having the indicated number of carbon atoms. Examples of alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, isobutyl, sec-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, and the like.
Examples of the term "sulfoxide-based solvent" include, but are not limited to, dimethyl sulfoxide.
Examples of the term "ketone-based solvent" include, but are not limited to, acetone or N-methylpyrrolidone, and the like.
Examples of the term "alcohol solvent" include, but are not limited to, methanol, ethanol, glycerol, t-butanol, or the like.
Examples of the term "ethereal solvent" include, but are not limited to, diethyl ether, tetrahydrofuran, methyl tert-butyl ether, or 1,4-dioxane, and the like.
Examples of the term "ester solvent" include, but are not limited to, ethyl formate, methyl acetate, ethyl acetate, propyl acetate, isobutyl acetate, ethyl butyrate, and the like.
Examples of the term "nitrile based solvent" include, but are not limited to, acetonitrile and the like.
Examples of the term "aromatic hydrocarbon solvent" include, but are not limited to, benzene, toluene, xylene, trifluorotoluene, fluorobenzene, or the like.
Examples of the term "amide-based solvent" include, but are not limited to, N-dimethylformamide or N, N-dimethylacetamide, and the like.
Examples of the term "haloalkane solvent" include, but are not limited to, dichloromethane, trichloromethane or 1,2-dichloroethane and the like.
Examples of the term "alkane solvent" include, but are not limited to, petroleum ether or n-hexane, and the like.
The above preferred conditions can be arbitrarily combined to obtain preferred embodiments of the present invention without departing from the common general knowledge in the art.
The reagents and starting materials used in the present invention are commercially available.
The positive progress effects of the invention are as follows: the bis-fluorosulfonyl imide is innovatively applied to organic synthesis reaction, can be used as a catalyst to efficiently catalyze various reactions, such as Friedel-Crafts reaction, esterification reaction, lactone ring-opening polymerization reaction, silyl ether polymerization reaction, carbonyl compound reduction etherification, alkynyl hydrolysis and the like, and has the advantages of mild reaction conditions, strong substrate adaptability and high atom economy.
Detailed Description
The invention is further illustrated by the following examples, which are not intended to limit the invention thereto. The experimental methods without specifying specific conditions in the following examples were selected according to the conventional methods and conditions, or according to the commercial instructions.
Preparation of example 1
Figure BDA0003719207890000221
10g of potassium bis (fluorosulfonyl) imide (45.6 mmol) and 10g of 98% concentrated sulfuric acid (100 mmol) are added into an autoclave, 60 g of sulfur dioxide is introduced at the temperature of 70 ℃, the temperature is slowly increased to the room temperature, a white solid is generated after the reaction for half an hour, then sulfur dioxide gas is slowly released, 50ml of dichloromethane is added, the solid is filtered, the solid is washed by 50ml of dichloromethane, the filtrate is dried in a spinning mode, reduced pressure distillation is carried out, a fraction of 85 ℃/20mm Hg is collected, 7.7g (42.5 mmol) of bis (fluorosulfonyl) imide is obtained, and a colorless liquid is obtained, and the yield is 93%.
19 F NMR (dichloromethane as solvent, trichlorofluoromethane as internal standard) +57.3.
Preparation of example 2
Figure BDA0003719207890000222
10g of sodium bis (fluorosulfonyl) imide (49.26 mmol) and 10g of 98% concentrated sulfuric acid (100 mmol) are added into an autoclave, 60 g of sulfur dioxide is introduced at the temperature of 70 ℃, the temperature is slowly raised to the room temperature, a white solid is generated after reaction for half an hour, then sulfur dioxide gas is slowly released, 50ml of dichloromethane is added, the solid is filtered, the solid is washed by 50ml of dichloromethane, the filtrate is dried in a spinning mode, reduced pressure distillation is carried out, 85 ℃/20mm Hg fractions are collected, 8.1g of bis (fluorosulfonyl) imide (44.75 mmol) is obtained, and colorless liquid is obtained, wherein the yield is 91%.
19 F NMR (dichloromethane as solvent, trichlorofluoromethane as internal standard) +57.3.
Example 1
Figure BDA0003719207890000223
1.9998g (17.54mmol, 1eq) caprolactone, 5ml dichloromethane, 175ul phenylpropanol dichloromethane solution (1 eq) with concentration of 1mol/L are added into a 25ml three-neck flask, 35ul bis (fluorosulfonyl) imide acid dichloromethane solution (0.1 eq) with concentration of 0.5mol/L is added under nitrogen protection, the mixture is reacted at room temperature overnight, the reaction solution is poured into 50ml cold n-hexane, solid is precipitated, filtered and dried to obtain 1.86g white polycaprolactone solid (yield 93%) which is detected by GPC, and Mn is detected PS =25267,PDI=1.03。
Example 2
Figure BDA0003719207890000231
A25 ml single neck flask was charged with 5.01g (16.92 mmol) octamethylcyclotetrasiloxane, hexamethylsilyl 0.0687g (0.424 mmol), magnetically stirred, charged with 0.12g bis-fluorosulfonylimide (0.66mmol, 4% mole relative to octamethylcyclotetrasiloxane) under nitrogen, and reacted overnight at room temperature to give a colorless viscous liquid as dimethylsilicone oil. Mn by GPC PS =9820,PDI=1.0。
Example 3
Figure BDA0003719207890000232
In a 20ml single-neck bottle were charged 3-ethynylaniline (0.1068g, 0.912mmol), sodium azide (0.065g, 1mmol), triethyl orthoformate (0.162g, 1.1mmol), glycerol (4 ml), bis-fluorosulfonylimide (91ul, 0.5m in dcm,5% mol, relative to 3-ethynylaniline), reacted overnight at room temperature, TLC (petroleum ether: ethyl acetate = 10) detected completion of the reaction of the starting material (3-ethynylaniline), 15ml of water was added, a solid was precipitated, and after filtration, washing with water, and drying, 0.13g (0.76 mmol) of a pale yellow solid was obtained in 84% yield. Melting point 98.6-100 deg.C.
1 H NMR(400MHz,CD 3 CN):3.38(s,1H),7.17-7.32(m,4H),8.10(s,1H).
Example 4
Figure BDA0003719207890000233
In a 20ml single neck flask were added 3-bromoaniline (0.1g, 0.58mmol), sodium azide (0.038g, 0.58mmol), triethyl orthoformate (0.104g, 0.7mmol), glycerol (4 ml), bis-fluorosulfonylimide (58ul, 0.5m in dcm,5% mol, relative to 3-bromoaniline), reacted overnight at room temperature, TLC (petroleum ether: ethyl acetate = 10) detected completion of the reaction of the starting material (3-bromoaniline), 15ml of water was added, a solid was precipitated, filtered, washed with water, and dried to give 0.113g (0.5 mmol) of a pale yellow solid in 86% yield. Melting point 184-186 ℃.
1 H NMR(400MHz,CDCl 3 ):6.91-6.93(d,2H),7.4-7.42(d,2H),8.08(s,1H)。
Example 5
Figure BDA0003719207890000241
In a 20ml single neck flask were charged 4-hexen-3-one (0.3095g, 3.15mmol), benzyl carbamate (0.476g, 3.15mmol), acetonitrile (6 ml), bis-fluorosulfonylimide (315ul, 0.5M in CH) 3 CN,5 mol%, relative to 4-hexen-3-one), reaction at room temperature for half an hour, TLC (petroleum ether: ethyl acetate = 10), rf =0.4, the starting material (4-hexen-3-one) was detected to be absent, and column chromatography purification gave 0.74g of a white solid with a yield of 95%.
1 H NMR(400MHz,CDCl 3 ):0.94-1.26(m,6H),2.28-2.68(m,4H),3.91-4.17(m,1H),5.08(m,3H),7.3-7.34(m,5H)
LC-MS:272(M+Na)。
Example 6
Figure BDA0003719207890000242
To a 20ml single-neck flask were added benzyl p-methoxyacetate (0.792g, 4.4mmol), methoxybenzene (0.476g, 4.4mmol) and methylene chloride (6 ml), and bis-fluorosulfonylimide (440ul, 0.5M in CH) 3 CN,5% mol, relative to benzyl p-methoxyacetate), reaction at room temperature for half an hour, TLC (petroleum ether: ethyl acetate = 10), rf =0.4, and the disappearance of the starting material (benzyl p-methoxyacetate) was detected, and spin-drying gave 0.95g (4.17 mmol) of a yellow oily body with a yield of 95%.
1 H NMR(400MHz,CDCl 3 ):3.80(s,6H),3.89(s,2H),6.83-7.13(m,8H)。
Example 7
Figure BDA0003719207890000243
P-aminophenylacetylene (0.2265g, 1.935mmol), water (0.1g, 5.56mmol), 1,4-dioxane (2.5 ml) were charged into a 20ml single-neck flask, bis-fluorosulfonylimide (35mg, 0.193mmol,10% mole, relative to p-aminophenylacetylene) was added, reaction was carried out at 100 ℃ for 8 hours, TLC (petroleum ether: ethyl acetate =5:2, rf = 0.3), detection of disappearance of the starting material (p-aminophenylacetylene) was detected, extraction was performed by adding ethyl acetate (20 ml), washing with water (20ml × 3), washing with saturated sodium chloride, drying over anhydrous sodium sulfate, and spin-drying to give 0.23g (1.7 mmol) of a yellow solid in 88% yield.
LC-MS:136(M+1)。
1 H NMR(400MHz,CD 3 CN):2.42(s,3H),4.79(s,2H),6.58-6.69(d,2H),7.68-7.79(d,2H)。
Example 8
Figure BDA0003719207890000251
In a 20ml single vial was added 4' -methoxychalcone (0.1157g, 0.486mmol), dichloromethane (3 ml), allyltrimethylsilane (66.4 mg,0.58mmol, 1.2eq), bis-fluorosulfonylimide (9mg, 0.0497mmol,10% mole, relative to 4' -methoxychalcone) was added under ice-bath conditions, slowly returned to room temperature for two hours, TLC (petroleum ether: ethyl acetate = 10), detection of disappearance of starting material (4 ' -methoxychalcone), washing with water (20ml × 3), washing with saturated sodium chloride, drying over anhydrous sodium sulfate, column chromatography purification (petroleum ether: ethyl acetate =10, rf = 0.4) to give 0.11g (0.393 mmol) of a pale yellow solid in 81% yield.
1 H NMR(400MHz,CDCl 3 ):2.4-2.48(m,2H),3.21-3.23(m,2H),3.41-3.48(m,1H),3.83(s,3H),4.92-5.00(m,2H),5.62-5.72(m,1H),6.86-6.89(m,2H),7.14-7.28(m,5H),7.85-7.88(m,2H)。
Example 9
Figure BDA0003719207890000252
A20 ml single-neck flask was charged with aniline (213mg, 2.29mmol), benzaldehyde (192mg, 1.81mmol) and bis-fluorosulfonylimide (98mg, 0.54mmol,30% mol, relative to benzaldehyde) and stirred for 5 minutes, followed by addition of acetophenone (360mg, 3mmol) and stirring at room temperature overnight. Column chromatography purification (n-hexane: ethyl acetate =10, 1, rf = 0.4) gave the product as a white solid 210mg (0.69 mmol) with a yield of 38%.
1 H NMR(400HMz,CDCl 3 ):3.39-3.53(m,2H),4.56(s,1H),4.99-5.02(q,1H),6.55-6.57(d,2H),6.64-6.68(t,2H),7.07-7.09(t,2H),7.21-7.26(m,2H),7.30-7.34(t,2H),7.43-7.46(m,3H),7.54-7.58(t,1H),7.90-7.92(d,2H)。
Example 10
Figure BDA0003719207890000261
Aniline (106mg, 1.14mmol), p-chlorobenzaldehyde (140mg, 1mmol) and acetophenone (240mg, 2mmol) were added to a 20ml single-neck flask, stirred well and bis-fluorosulfonylimide (54mg, 0.298mmol,30% mol relative to p-chlorobenzaldehyde) was added and reacted overnight at room temperature. TLC (n-hexane: ethyl acetate =10 = 1) detects disappearance of aniline and formaldehyde, and column chromatography purification (n-hexane: ethyl acetate =10, rf = 0.4) gives 100mg (0.298 mmol) of the product as a white solid with a yield of 30%.
1 H NMR(400MHz,CDCl3):3.37-3.49(m,2H),4.44(brs,1H),4.94-4.97(t,1H),6.51-6.52(d,2H),6.66-6.68(t,1H),7.06-7.10(t,2H),7.24-7.28(t,2H),7.36-7.38(d,2H),7.42-7.46(t,2H),7.78-7.79(d,2H)。
Example 11
Figure BDA0003719207890000262
Phenyl acetate (220mg, 1.62mmol) and bis-fluorosulfonylimide (360mg, 1.99mmol) were added to a 10ml single-necked flask, the reaction was stirred at room temperature overnight, phenyl acetate disappeared by TLC (petroleum ether: ethyl acetate = 3:1) and column chromatography purification (petroleum ether: ethyl acetate =3, rf = 0.3) gave 50mg (0.367 mmol) of a yellow solid in 23% yield.
1 H NMR(400MHz,d-DMSO):2.43(s,3H),6.79-6.81(d,2H),7.78-7.80(d,2H),10.30(s,1H)。
Example 12
Figure BDA0003719207890000271
Phenyl acetate (330mg, 2.4 mmol) and bis-fluorosulfonylimide (540mg, 2.98mmol) were added to a 10ml single-necked flask, and the reaction was stirred at 60 ℃ for 3h, disappearance of phenyl acetate was detected by tlc (petroleum ether: ethyl acetate = 3:1), and column chromatography purification (petroleum ether: ethyl acetate =3, rf = 0.3) gave 100mg (0.735 mmol) of a yellow solid in 30% yield.
1 H NMR(400MHz,d-DMSO):2.43(s,3H),6.79-6.81(d,2H),7.78-7.80(d,2H),10.30(s,1H)。
Example 13
Figure BDA0003719207890000272
In a 25ml three-necked flask were added benzoic acid (0.21g, 1.72mmol), anhydrous methanol (0.3g, 9.375mmol) and toluene (1 ml) under nitrogen protection and bis-fluorosulfonylimide (31mg, 0.171mol,10% mol, relative to benzoic acid), the reaction was stirred at 85 ℃ for 12h, disappearance of benzoic acid was detected by tlc (petroleum ether: ethyl acetate = 30), column chromatography purification (petroleum ether: ethyl acetate =30, rf = 0.4) gave 160mg (1.18 mmol) of colorless oily liquid, yield 68.6%.
1 H NMR(400MHz,CDCl 3 ):3.92(s,3H),7.42-7.45(t,2H),7.53-7.55(t,2H),8.03-8.05(d,2H)。
Example 14
Figure BDA0003719207890000273
In a 25ml single vial was added benzaldehyde (0.2198g, 2.07mmol), triethylsilane (0.27g, 2.327mmol) and dichloromethane (1 ml) under nitrogen protection and bis-fluorosulfonylimide (42ul, 0.5m in dichloromethane, 1% mol, relative to benzaldehyde) was added, the reaction was stirred at room temperature for 30 minutes, disappearance of benzaldehyde was detected by TLC (petroleum ether: ethyl acetate = 30), column chromatography purification (petroleum ether: ethyl acetate =30, rf = 0.4) gave 160mg (0.808 mmol) as a colorless oily liquid with a yield of 78%.
1 H NMR(400MHz,CDCl 3 ):4.59(s,4H),7.38-7.40(m,10H)。
Example 15
Figure BDA0003719207890000281
In a 25ml single neck flask were added 4-chlorobenzaldehyde (0.32g, 2.286 mmol), triethylsilane (0.2927g, 2.52mmol) and dichloromethane (1 ml) under nitrogen protection and bis-fluorosulfonylimide (45ul, 0.5m in dichloromethane, 1% mole, relative to 4-chlorobenzaldehyde) and the reaction was stirred at room temperature for 30 minutes, TLC (petroleum ether: ethyl acetate = 30) detected disappearance of benzaldehyde and column chromatography purification (petroleum ether: ethyl acetate =30, rf = 0.4) gave 260mg (0.974 mmol) of white solid in 86% yield.
1 H NMR(400MHz,CDCl 3 ):4.52(s,4H),7.28-7.35(m,8H)。
Example 16
Figure BDA0003719207890000282
In a 25ml single vial was added 3-methylbenzaldehyde (0.1387 g, 1.156mmol), triethylsilane (0.151g, 1.3 mmol) and dichloromethane (1 ml) under nitrogen protection, bis-fluorosulfonylimide (23ul, 0.5m dichloromethane solution, 1% mol, relative to 3-methylbenzaldehyde) was added, the reaction was stirred at room temperature for 30 minutes, disappearance of benzaldehyde was detected by TLC (petroleum ether: ethyl acetate = 30), and column chromatography purification (petroleum ether: ethyl acetate =30, rf = 0.6) gave 130mg (0.575 mmol) of a white solid with a yield of 99%.
1 H NMR(400MHz,CDCl 3 ):2.35(s,6H),4.52(s,4H),7.09-7.26(m,8H)。
Example 17
Figure BDA0003719207890000283
In a 25ml single vial was added 4-methylbenzaldehyde (0.1507g, 1.256 mmol), triethylsilane (0.16g, 1.38mmol) and dichloromethane (1 ml) under nitrogen protection, bis-fluorosulfonylimide (25ul, 0.5m in dichloromethane, 1% mol, relative to 4-methylbenzaldehyde) was added, the reaction was stirred at room temperature for 1 hour, disappearance of benzaldehyde was detected by TLC (petroleum ether: ethyl acetate = 30), column chromatography purification (petroleum ether: ethyl acetate =30, rf = 0.5) gave 131mg (0.58 mmol) of a white solid in 92% yield.
1 H NMR(400MHz,CDCl 3 ):2.35(s,6H),4.5(s,4H),7.14-7.17(d,4H),7.24-7.26(d,4H)。
Example 19
Figure BDA0003719207890000291
250ul of a deuterated acetonitrile solution of tris (trimethylsilyl) silane (0.5M) was added to a 10ml single-neck flask, and then 250ul of a deuterated acetonitrile solution of bis (fluorosulfonyl) imide (0.5M) was slowly added thereto under ice-cooling, and the reaction was carried out for 1 hour after slowly returning to room temperature. Thus obtaining the target product solution.
19 F NMR (deuterated acetonitrile as solvent, monofluorotrichloromethane as internal standard): +54
1 H NMR(400MHz,d-CD 3 CN):0.17(S)。
Example 19
Figure BDA0003719207890000292
Benzotriazole (0.111g, 0.933mmol), 1- (trifluoromethyl) -3,3-dimethyl-1,2-benziodoxolane (0.2g, 0.6 mmol), acetonitrile (6 ml), bis-fluorosulfonylimide (12mg, 0.066mmol,10 mol%, relative to 1- (trifluoromethyl) -3,3-dimethyl-1,2-benziodoxolane), was added to a 20ml single-neck flask and reacted at 60 ℃ for 3.5 hours, TLC (petroleum ether: ethyl acetate = 5:2), 1- (trifluoromethyl) -3,3-dimethyl-1,2-benziodoxolane was detected to disappear, and the product was quantified by fluorine spectrometry in 83% yield (using trifluorotoluene as an internal standard).
19 F NMR (acetonitrile as solvent, trichlorofluoromethane as internal standard): 53;
LC-MS:229(M+1)。
comparative example 1
Figure BDA0003719207890000301
This comparative example is selected from the document org.lett., vol.5, no.12,2003.
4-hexen-3-one (0.5mmol, 1.0eq) with benzyl carbamate (0.75mmol, 1.5eq), acetonitrile (1 ml), bis (trifluoromethane) sulfonimide (0.05mmol, 10 eq) was added, reacted at-20 ℃ for 10min to give 117mg of product in 95% yield. The bis (trifluoromethanesulfonyl) imide has large using amount and harsh reaction conditions, and needs to be carried out at the temperature of minus 20 ℃.
Comparative example 2
Figure BDA0003719207890000302
This comparative example was selected from J.org.chem.1987,52,4314-4319.
In the reductive etherification of a carbonyl compound, trimethylsilyl trifluoromethanesulfonate (Trimethylsilyl Triflate,44.45mg,0.20mmol,10% eq) and triethylsilylhydride (0.465g, 4mmol, 2eq) were dissolved in 4ml of dichloromethane as described in experimental method a on page 4318 of this document, benzaldehyde (0.212g, 2mmol, 1eq) was added under ice bath, reacted at room temperature for 2 hours, and purified by column chromatography (petroleum ether: ethyl acetate =30, rf = 0.4) to give 0.1299g of a colorless oily liquid in a yield of 65.6%.
1 H NMR(400MHz,CDCl 3 ):4.59(s,4H),7.38-7.40(m,10H)。

Claims (30)

1. The application of the bis (fluorosulfonyl) imide as a catalyst in the preparation of tetrazole compounds shown in the formula (III) comprises the following steps:
in a solvent, under the action of bis (fluorosulfonyl) imide, reacting a compound shown as a formula (III-A), an orthoformate compound shown as a formula (III-B) and sodium azide to obtain a tetrazole compound shown as a formula (III);
Figure FDA0003719207880000011
wherein R is 6 Is C1-C16 alkyl, C6-C10 aryl or R B Substituted C6-C10 aryl, R B Is halogen or C2-C4 alkynyl;
R 6-1 is methyl or ethyl.
2. The use according to claim 1, wherein R is 6 Wherein said C1-C16 alkyl is C1-C10 alkyl, such as C1-C6 alkyl;
and/or, R 6 Wherein said C6-C10 aryl and said R B C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, R 6 In (1), the R B R in substituted C6-C10 aryl B The number of substitution(s) is 1 to 3 (e.g., 1), and each R B The same or different;
and/or, R B Wherein said halogen is fluorine, chlorine, bromine or iodine, for example bromine;
and/or, R B Wherein said C2-C4 alkynyl is ethynyl;
and/or in the preparation of the tetrazole compound shown in the formula (III), the usage amount of the bis (fluorosulfonyl) imide is 1% -10% (for example, 5%) of the molar amount of the compound shown in the formula (III-A);
and/or in the preparation of the tetrazole compound shown in the formula (III), the molar ratio of the compound shown in the formula (III-A) to the orthoformate compound shown in the formula (III-B) is 1: (1-2), further example 1:1.2
And/or in the preparation of the tetrazole compound shown in the formula (III), the molar ratio of the compound shown in the formula (III-A) to the sodium azide is 1: (1-3), for example, 1:1 or 1:1.1;
and/or in the preparation of the tetrazole compound shown in the formula (III), the solvent is one or more of a propyl sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; preferably one or more of glycerol, tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide and 1,4-dioxane, such as glycerol;
and/or, in the preparation of the tetrazole compound shown in the formula (III), the reaction temperature is 20 ℃ to the reflux temperature of the solvent, such as room temperature;
and/or in the preparation of the tetrazole compound shown in the formula (III), the reaction time is 2-12 hours.
3. The use of claim 1, wherein R is 6 Is R B Substituted phenyl radicals, R B Is halogen or ethynyl; preferably, R is 6 Is composed of
Figure FDA0003719207880000021
4. The application of bis (fluorosulfonyl) imide as a catalyst in the preparation of a compound shown as a formula (IV) comprises the following steps:
in Sup>A solvent, under the action of bis (fluorosulfonyl) imide, carrying out addition reaction on Sup>A compound shown as Sup>A formulSup>A (IV-A) and Sup>A compound shown as Sup>A formulSup>A (IV-B) to obtain Sup>A compound shown as Sup>A formulSup>A (IV);
Figure FDA0003719207880000022
wherein the content of the first and second substances,
x is NH, S or O;
R 7 、R 8 and R 9 Independently is C1-C16 alkyl, C6-C10 aryl, R C Substituted C6-C10 aryl or
Figure FDA0003719207880000023
R C Is halogen, C1-C6 alkyl or C1-C6 alkoxy.
5. The use of claim 4, wherein R is 7 、R 8 Or R 9 The C1-C16 alkyl group is a C1-C10 alkyl group, preferably a C1-C6 alkyl group (e.g., a C1-C3 alkyl group, further e.g., a methyl group, an ethyl group, an n-propyl group or an isopropyl group);
and/or, R 7 、R 8 Or R 9 Wherein said C6-C10 aryl and said R C C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, R 7 、R 8 Or R 9 In (1), the R C R in substituted benzyl C The number of substitution(s) is 1 to 3 (e.g., 1), and each R C The same or different;
and/or, R C Wherein said halogen is fluorine, chlorine, bromine or iodine;
and/or, R C Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or, R C Wherein said C1-C6 alkoxy is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy;
and/or, X is NH;
and/or, in the preparation of the compound shown in the formulSup>A (IV), the usage amount of the bis-fluorosulfonyl imide is 1% -10% (for example, 5%) of the molar amount of the compound shown in the formulSup>A (IV-A);
and/or in the preparation of the compound shown as the formulSup>A (IV), the molar ratio of the compound shown as the formulSup>A (IV-A) to the compound shown as the formulSup>A (IV-B) is 1 (1-10), and further for example, 1:1;
and/or in the preparation of the compound shown in the formula (IV), the solvent is one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; such as one or more of tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide, and 1,4-dioxane, further such as acetonitrile;
and/or, in the preparation of the compound shown in the formula (IV), the temperature of the addition reaction is 20 ℃ to the reflux temperature of the solvent, such as room temperature;
and/or in the preparation of the compound shown in the formula (IV), the time of the addition reaction is 10 minutes to 12 hours, such as 0.5 hour.
6. The use of claim 4, wherein R is 7 And R 8 Independently C1-C16 alkyl, for example C1-C10 alkyl, further for example C1-C6 alkyl (for example C1-C3 alkyl, further for example methyl, ethyl, n-propyl or isopropyl); preferably, the compound shown in the formulSup>A (IV-A) is
Figure FDA0003719207880000031
And/or, R 9 Is composed of
Figure FDA0003719207880000032
Preferably, the compound shown in the formula (IV-B) is
Figure FDA0003719207880000033
7. The application of the bis (fluorosulfonyl) imide as a catalyst in the preparation of a compound shown as a formula (V) comprises the following steps:
in Sup>A solvent, under the action of bis (fluorosulfonyl) imide, carrying out Friedel-crafts reaction on Sup>A compound shown as Sup>A formulSup>A (V-A) and Sup>A compound shown as Sup>A formulSup>A (V-B) to obtain Sup>A compound shown as Sup>A formulSup>A (V);
Figure FDA0003719207880000041
wherein Y is halogen,
Figure FDA0003719207880000042
R 10 Is C1-C16 alkyl, benzyl, C6-C10 aryl, R D Substituted C6-C10 aryl or R E Substituted benzyl, R D And R E Independently is halogen, C1-C6 alkyl or C1-C6 alkoxy;
R 11 is C1-C6 alkyl or C1-C6 alkoxy.
8. Use according to claim 7, wherein in Y the halogen is fluorine, chlorine, bromine or iodine, for example chlorine, bromine or iodine;
and/or, R 10 Wherein said C1-C16 alkyl is C1-C10 alkyl, such as C1-C6 alkyl (e.g., C1-C3 alkyl, further such as methyl, ethyl, n-propyl or isopropyl);
and/or, R 10 Wherein said C6-C10 aryl and said R D C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, R 10 In (1), the R D R in substituted C6-C10 aryl D The number of substitution(s) is 1 to 3 (e.g., 1), and each R D The same or different;
and/or, R 10 In (1), the R E R in substituted benzyl E The number of substitution(s) is 1 to 3 (e.g., 1), and each R E The same or different;
and/or, R D Or R E Wherein said halogen is fluorine, chlorine, bromine or iodine;
and/or, R D 、R E Or R 11 Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or, R D 、R E Or R 11 Wherein said C1-C6 alkoxy is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy;
and/or Y is
Figure FDA0003719207880000043
And/or, in the preparation of the compound shown in the formula (V), the usage amount of the bis-fluorosulfonyl imide is 0.1% -10% (for example, 5%) of the molar amount of the compound shown in the formula (V-B);
and/or, in the preparation of the compound shown as the formulSup>A (V), the molar ratio of the compound shown as the formulSup>A (V-A) to the compound shown as the formulSup>A (V-B) is (1-10): 1, such as 1:1;
and/or in the preparation of the compound shown in the formula (V), the solvent is one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; such as one or more of dichloromethane, tetrahydrofuran, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide, and 1,4-dioxane, further such as dichloromethane;
and/or, in the preparation of the compound shown in the formula (V), the temperature of the Friedel-crafts reaction is 20 ℃ to the reflux temperature of the solvent, such as room temperature;
and/or in the preparation of the compound shown in the formula (V), the time of the Friedel-crafts reaction is 5 minutes to 12 hours, such as 0.5 hour.
9. The use of claim 7, wherein R is D And R E Independently is a C1-C6 alkoxy group; preferably, R 10 Is benzyl, phenyl, R D Substituted phenyl or R E A substituted benzyl group; more preferably, the compound represented by the formulSup>A (V-A) is
Figure FDA0003719207880000051
And/or, R 11 Is C1-C6 alkoxy; preferably, the compound represented by the formula (V-B) is
Figure FDA0003719207880000052
10. The application of bis (fluorosulfonyl) imide as a catalyst in the preparation of a compound shown as a formula (VI) comprises the following steps:
in a solvent, under the action of bis (fluorosulfonyl) imide, performing hydrolysis reaction on a compound shown as a formula (VI-A) and water to obtain a compound shown as a formula (VI);
Figure FDA0003719207880000053
wherein R is 12 Is C1-C16 alkyl, C6-C10 aryl or R F Substituted C6-C10 aryl, R F Is an amino group.
11. The use according to claim 10, wherein R is 12 C1-C16 alkyl is C1-C10 alkyl, for example C1-C6 alkyl (e.g. C1-C3 alkyl, again for example methyl, ethyl, n-propyl or isopropyl);
and/or, R 12 Wherein said C6-C10 aryl and said R F C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, R 12 In (1), the R F R in substituted C6-C10 aryl F The number of substitution(s) is 1 to 3 (e.g., 1), and each R F The same or different;
and/or, in the preparation of the compound shown in the formula (VI), the usage amount of the bis-fluorosulfonyl imide is 5% -30% (for example, 10%) of the molar amount of the compound shown in the formula (VI-A);
and/or, in the preparation of the compound shown in the formula (VI), the molar ratio of the compound shown in the formula (VI-A) to water is 1 (1-10), such as 1;
and/or in the preparation of the compound shown in the formula (VI), the solvent is one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; such as one or more of dichloromethane, tetrahydrofuran, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide, and 1,4-dioxane, further such as 1,4-dioxane;
and/or, in the preparation of the compound shown in the formula (VI), the temperature of the hydrolysis reaction is 20 ℃ to the reflux temperature of the solvent, such as 100 ℃;
and/or in the preparation of the compound shown in the formula (VI), the hydrolysis reaction time is 2-12 hours, such as 8 hours.
12. The application of bis (fluorosulfonyl) imide as a catalyst in the preparation of a compound shown as a formula (VII) comprises the following steps:
in a solvent, under the action of bis (fluorosulfonyl) imide, reacting a compound shown as a formula (VII-A) with allyl trimethylsilane to obtain a compound shown as a formula (VII);
Figure FDA0003719207880000061
wherein R is 13 And R 14 Independently is C1-C16 alkyl, C6-C10 aryl or R G Substituted C6-C10 aryl, R G Is halogen, C1-C6 alkyl or C1-C6 alkoxy.
13. The use of claim 12, wherein R is 13 Or R 14 In (1-16), the C1-C10 alkyl group is a C1-10 alkyl group, for exampleIs C1-C6 alkyl (e.g., C1-C3 alkyl, further e.g., methyl, ethyl, n-propyl, or isopropyl);
and/or, R 13 Or R 14 Wherein said C6-C10 aryl and said R G C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, R G Halogen is fluorine, chlorine, bromine or iodine, for example chlorine;
and/or, R G Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or, R G Wherein said C1-C6 alkoxy is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy;
and/or, R 13 Or R 14 In (1), the R G R in substituted C6-C10 aryl G The number of substitution(s) is 1 to 3 (e.g., 1), and each R G The same or different;
and/or in the preparation of the compound shown in the formula (VII), the usage amount of the bis-fluorosulfonyl imide is 5% -30%, for example 10% of the molar weight of the compound shown in the formula (VII-A);
and/or, in the preparation of the compound shown in the formula (VII), the molar ratio of the compound shown in the formula (VII-A) to the allyltrimethylsilane is 1 (1-10), such as 1.2;
and/or in the preparation of the compound shown in the formula (VII), the solvent is one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; such as one or more of dichloromethane, tetrahydrofuran, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide, and 1,4-dioxane, further such as dichloromethane;
and/or, in the preparation of the compound represented by the formula (VII), the reaction temperature is-20 ℃ to room temperature, such as room temperature;
and/or in the preparation of the compound shown as the formula (VII), the reaction time is 2-12 hours, such as 2 hours.
14. The use of claim 12, wherein R is 13 And R 14 Independently is phenyl or R G Substituted phenyl radicals, R G Is C1-C3 alkoxy; preferably, the compound shown in the formula (VII-A) is
Figure FDA0003719207880000071
15. The application of bis (fluorosulfonyl) imide as a catalyst in preparation of a compound shown as a formula (VIII) comprises the following steps:
under the action of bis (fluorosulfonyl) imide, reacting a compound shown as a formula (VIII-A), a compound shown as a formula (VIII-B) and a compound shown as a formula (VIII-C) to obtain a compound shown as a formula (VIII);
Figure FDA0003719207880000072
wherein R is 15 、R 16 、R 17 、R 18 、R 19 And R 20 Independently H, C, C6-C10 alkyl, C1-C16 aryl or R H Substituted C6-C10 aryl, R H Is halogen, C1-C6 alkyl or C1-C6 alkoxy.
16. The use of claim 15, wherein R is 15 、R 16 、R 17 、R 18 、R 19 Or R 20 Wherein said C1-C16 alkyl is C1-C10 alkyl, such as C1-C6 alkyl (e.g., C1-C3 alkyl, further such as methyl, ethyl, n-propyl or isopropyl);
and/or, R 15 、R 16 、R 17 、R 18 、R 19 Or R 20 Wherein said C6-C10 aryl and said R H C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, R H Halogen is fluorine, chlorine, bromine or iodine, for example chlorine;
and/or, R H Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or, R H Wherein said C1-C6 alkoxy is C1-C3 alkoxy, such as methoxy, ethoxy, n-propoxy or isopropoxy;
and/or, R 15 、R 16 、R 17 、R 18 、R 19 Or R 20 In (1), the R H R in substituted C6-C10 aryl H The number of substitution(s) is 1 to 3 (e.g., 1), and each R H The same or different;
and/or in the preparation of the compound shown in the formula (VIII), the usage amount of the bis-fluorosulfonyl imide is 1% -100%, such as 10% -50%, and further such as 30% of the molar weight of the compound shown in the formula (VIII-B);
and/or, in the preparation of the compound of formula (VIII), the molar ratio of the compound of formula (VII-A) to the compound of formula (VIII-B) is (1-2): 1, e.g. 1.1 or 1.3;
and/or in the preparation of the compound shown in the formula (VIII), the molar ratio of the compound shown in the formula (VII-A) to the compound shown in the formula (VIII-C) is 1: (1-3), such as 1.3, 1.8, or 1:2;
and/or, in the preparation of the compound represented by the formula (VIII), the reaction is carried out in a solvent or in the absence of a solvent, wherein the solvent is one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent, such as one or more of tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide and 1,4-dioxane; preferably, the reaction is carried out in the absence of a solvent;
and/or, in the preparation of the compound shown in the formula (VIII), the reaction temperature is between room temperature and 50 ℃, for example, room temperature;
and/or in the preparation of the compound shown in the formula (VIII), the reaction time is 2-12 hours.
17. The use of claim 15, wherein R is 15 、R 16 、R 17 、R 18 、R 19 And R 20 Independently is H, C-C6 alkyl, phenyl or R H Substituted phenyl radicals, R H Is halogen, C1-C3 alkyl or C1-C3 alkoxy;
preferably, the compound shown in the formula (VIII-A) is
Figure FDA0003719207880000081
Preferably, the compound represented by the formula (VIII-B) is
Figure FDA0003719207880000091
Preferably, the compound represented by the formula (VIII-C) is
Figure FDA0003719207880000092
18. The application of bis (fluorosulfonyl) imide as a catalyst in the preparation of a compound shown as a formula (X) comprises the following steps:
under the action of bis (fluorosulfonyl) imide, reacting a compound shown as a formula (X-A) with a compound shown as a formula (X-B) to obtain a compound shown as a formula (X);
Figure FDA0003719207880000093
wherein R is 22 Is H, C-C16 alkyl, C6-C10 aryl or R J Substituted C6-C10 aryl; r 23 Is C1-C16 alkyl, C6-C10 aryl or R K Substituted C6-C10 aryl, R J And R K Independently halogen, C1-C6 alkyl or C1-C6 alkoxy.
19. The use of claim 18, wherein R is 22 Or R 23 Wherein said C1-C16 alkyl is C1-C10 alkyl, such as C1-C6 alkyl (e.g., C1-C3 alkyl, further such as methyl, ethyl, n-propyl or isopropyl);
and/or, R 22 Or R 23 Wherein said C6-C10 aryl, said R J Substituted C6-C10 aryl and said R K C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, R J Or R K Halogen is fluorine, chlorine, bromine or iodine, for example chlorine;
and/or, R J Or R K Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or, R J Or R K Wherein said C1-C6 alkoxy is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy;
and/or, R 22 In (1), the R J R in substituted C6-C10 aryl J The number of substitution(s) is 1 to 3 (e.g., 1), and each R J The same or different;
and/or, R 23 In (1), the R K R in substituted C6-C10 aryl K The number of substitution(s) is 1 to 3 (e.g., 1), and each R K The same or different;
and/or in the preparation of the compound shown in the formula (X), the usage amount of the bis-fluorosulfonyl imide is 0.1-10%, for example 10% of the molar weight of the compound shown in the formula (X-A);
and/or, in the preparation of the compound shown in the formula (X), the molar ratio of the compound shown in the formula (X-A) to the compound shown in the formula (X-B) is 1 (1-10), such as 1;
and/or, in the preparation of the compound represented by formula (X), the reaction is carried out in a solvent or in the absence of a solvent, the solvent being one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent, such as one or more of tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide and 1,4-dioxane, such as toluene; preferably, the reaction is carried out in the absence of a solvent;
and/or, in the preparation of the compound represented by formula (X), the temperature of the reaction is room temperature — the reflux temperature of the solvent used, for example 85 ℃;
and/or, in the preparation of the compound shown in the formula (X), the reaction time is 2-12 hours, such as 12 hours.
20. The application of the bis (fluorosulfonyl) imide as a catalyst in the reduction etherification reaction of a carbonyl compound shown in a formula (XI-A) comprises the following steps:
in a solvent, under the action of bis (fluorosulfonyl) imide and a silane compound shown in a formula (XI-B), a carbonyl compound shown in a formula (XI-A) is subjected to reduction etherification reaction to prepare a compound shown in a formula (XI);
Figure FDA0003719207880000101
wherein R is 24 And R 25 Independently is H, C-C16 alkyl, C6-C10 aryl or R L Substituted C6-C10 aryl, R L Is halogen, C1-C6 alkyl or C1-C6 alkoxy; r is 24-1 Is C1-C3 alkyl.
21. The use of claim 20, wherein R is 24 Or R 25 C1-C16 alkyl is C1-C10 alkyl, for example C1-C6 alkyl (e.g. C1-C3 alkyl, again for example methyl, ethyl, n-propyl or isopropyl);
and/or, R 24 Or R 25 Wherein said C6-C10 aryl and said R L Of substituted C6-C10 aryl groupsC6-C10 aryl is independently phenyl;
and/or, R L Halogen is fluorine, chlorine, bromine or iodine, for example chlorine;
and/or, R L Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or, R L Wherein said C1-C6 alkoxy is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy;
and/or, R 24 Or R 25 In (1), the R L R in substituted C6-C10 aryl L The number of substitution(s) is 1 to 3 (e.g., 1), and each R L The same or different;
and/or, R 24-1 Is methyl, ethyl, n-propyl or isopropyl;
and/or in the reduction etherification reaction of the carbonyl compound shown in the formula (XI-A), the usage amount of the bis-fluorosulfonyl imide is 0.1-10%, for example 0.1-5%, and further for example 1% of the molar weight of the carbonyl compound shown in the formula (XI-A);
and/or in the reduction etherification reaction of the carbonyl compound shown in the formula (XI-A), the molar ratio of the carbonyl compound shown in the formula (XI-A) to the silane compound shown in the formula (XI-B) is 1 (1-2), such as 1;
and/or in the reduction etherification reaction of the carbonyl compound shown in the formula (XI-A), the solvent is one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; such as one or more of tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide, and 1,4-dioxane, such as dichloromethane;
and/or, in the reduction etherification reaction of the carbonyl compound shown in the formula (XI-A), the temperature of the reduction etherification reaction is 0-room temperature, such as room temperature;
and/or in the reductive etherification reaction of the carbonyl compound shown in the formula (XI-A), the time of the reductive etherification reaction is 5 minutes to 12 hours, such as 0.5 hour or 1 hour.
22. The use of claim 20, wherein R is 24 And R 25 Independently is H, phenyl or R L Substituted phenyl, preferably said carbonyl compound of formula (XI-A) is
Figure FDA0003719207880000111
Figure FDA0003719207880000112
23. A preparation method of silicon bis (fluorosulfonyl) imide shown in formula (XII) comprises the following steps:
reacting the compound shown in the formula (XII-A) with bis (fluorosulfonyl) imide to obtain bis (fluorosulfonyl) imide acid silicone ester shown in the formula (XII);
Figure FDA0003719207880000121
wherein Z is H, halogen, C1-C16 alkyl, C6-C10 aryl or R N Substituted C6-C10 aryl, R 26 、R 27 And R 28 Independently is C1-C16 alkyl, C6-C10 aryl, R M Substituted C6-C10 aryl or
Figure FDA0003719207880000122
R 29 、R 30 And R 31 Independently is C1-C6 alkyl, R M And R N Independently halogen, C1-C6 alkyl or C1-C6 alkoxy.
24. The method of claim 23, wherein Z, R is prepared 26 、R 27 Or R 28 In (1), the C1-C16 alkyl group is a C1-C10 alkyl group, for example, a C1-C6 alkyl group (e.g., a C1-C3 alkyl group)Radicals such as the methyl, ethyl, n-propyl or isopropyl radical);
and/or, Z, R 26 、R 27 Or R 28 Wherein said C6-C10 aryl, said R N Substituted C6-C10 aryl and said R M C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, Z, R M Or R N Halogen is fluorine, chlorine, bromine or iodine, for example chlorine;
and/or, R M Or R N Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or, R M Or R N Wherein said C1-C6 alkoxy is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy;
and/or, R 26 、R 27 Or R 28 In (1), the R M R in substituted C6-C10 aryl M The number of substitution(s) is 1 to 3 (e.g., 1), and each R M The same or different;
and/or, in Z, the R N R in substituted C6-C10 aryl N The number of substitution(s) is 1 to 3 (e.g., 1), and each R N The same or different;
and/or, R 29 、R 30 Or R 31 Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or in the preparation method of the bis (fluorosulfonyl) imide silicon ester shown in the formula (XII), the molar ratio of the compound shown in the formula (XII-A) to the bis (fluorosulfonyl) imide is (1-10): 1, such as 1:1;
and/or in the preparation method of the bis-fluorosulfonyl imidic acid silicone ester shown in the formula (XII), the reaction is carried out in a solvent or in the absence of a solvent, wherein the solvent is one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; such as one or more of tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide, and 1,4-dioxane, further such as acetonitrile or dichloromethane; preferably, the reaction is carried out in the absence of a solvent;
and/or in the preparation method of the bis (fluorosulfonyl) imide silicon ester shown in the formula (XII), the reaction temperature is 0-room temperature, such as room temperature;
and/or in the preparation method of the bis (fluorosulfonyl) imide silicon ester shown in the formula (XII), the reaction time is 30 minutes to 2 hours, such as 1 hour.
25. The method of claim 23, wherein R is 26 、R 27 And R 28 Independently is
Figure FDA0003719207880000131
R 29 、R 30 And R 31 Independently a C1-C3 alkyl group (e.g., methyl, ethyl, n-propyl, or isopropyl);
and/or, Z is H or halogen, preferably, Z is H.
26. Use of a bis-fluorosulfonyl imide as a catalyst in a rearrangement reaction of a compound of formula (IX), comprising the steps of:
in a solvent, carrying out rearrangement reaction on the compound shown in the formula (IX) under the action of bis (fluorosulfonyl) imide to obtain the compound shown in the formula (IX-A) and/or the compound shown in the formula (IX-B);
Figure FDA0003719207880000132
wherein R is 21 Is C1-C16 alkyl, C6-C10 aryl or R I Substituted C6-C10 aryl, R I Is halogen, C1-C6 alkyl or C1-C6 alkoxy.
27. The use of claim 26, wherein R is 21 In (1), the C1-C16 alkyl groupIs C1-C10 alkyl, for example C1-C6 alkyl (for example C1-C3 alkyl, for example methyl, ethyl, n-propyl or isopropyl);
and/or, R 21 Wherein said C6-C10 aryl group and said R I C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, R I Wherein said halogen is fluorine, chlorine, bromine or iodine, for example chlorine;
and/or, R I Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or, R I Wherein said C1-C6 alkoxy is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy;
and/or, R 21 In (1), the R I R in substituted C6-C10 aryl I The number of substitution(s) is 1 to 3 (e.g., 1), and each R I The same or different;
and/or, in the rearrangement reaction of the compound shown as the formula (IX), the usage amount of the bis-fluorosulfonyl imide is 20% -150%, such as 100% -150%, and 123% or 124% of the molar amount of the compound shown as the formula (IX);
and/or in the rearrangement reaction of the compound shown in the formula (IX), the rearrangement reaction is carried out in a solvent or in the absence of a solvent, wherein the solvent is one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, a nitrile solvent, an aromatic hydrocarbon solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; such as one or more of tetrahydrofuran, dichloromethane, ethyl acetate, acetonitrile, dimethyl sulfoxide, N-dimethylformamide, and 1,4-dioxane; preferably, the rearrangement reaction is carried out in the absence of a solvent;
and/or, in the rearrangement reaction of the compound shown in the formula (IX), the temperature of the rearrangement reaction is 20-150 ℃, such as room temperature and 60 ℃;
and/or, in the rearrangement reaction of the compound shown in the formula (IX), the time of the rearrangement reaction is 2 to 12 hours, such as 3 hours.
28. Use of a bis-fluorosulfonyl imide as a catalyst in the preparation of a compound of formula (XIII), comprising the steps of:
under the action of bis-fluorosulfonyl imide, reacting a compound shown as a formula (XIII-A), a compound shown as a formula (XIII-B) and a compound shown as a formula (XIII-C) to obtain a compound shown as a formula (XIII);
Figure FDA0003719207880000141
wherein Q is CH or N;
R 32 is halogen, C1-C16 alkyl, C6-C10 aryl or R O Substituted C6-C10 aryl;
m 3 is 0, 1,2, 3 or 4;
R 33 is C1-C16 alkyl, C6-C10 aryl or R P Substituted C6-C10 aryl;
R O and R P Independently halogen, C1-C6 alkyl or C1-C6 alkoxy.
29. The use of claim 28, wherein R is 32 Halogen is fluorine, chlorine, bromine or iodine, for example chlorine;
and/or, R 32 Or R 33 The C1-C16 alkyl group is, for example, a C1-C10 alkyl group, and further, for example, a C1-C6 alkyl group (for example, a C1-C3 alkyl group, and further, for example, a methyl group, an ethyl group, a n-propyl group or an isopropyl group);
and/or, R 32 Or R 33 Wherein said C6-C10 aryl, said R O Substituted C6-C10 aryl and said R P C6-C10 aryl of the substituted C6-C10 aryl is independently phenyl;
and/or, R O Or R P Halogen is fluorine, chlorine, bromine or iodine, for example chlorine;
and/or, R O Or R P Wherein said C1-C6 alkyl is C1-C3 alkyl, such as methyl, ethyl, n-propyl or isopropyl;
and/or, R O Or R P Wherein said C1-C6 alkoxy is a C1-C3 alkoxy group such as methoxy, ethoxy, n-propoxy or isopropoxy;
and/or, R 32 In (1), the R O R in substituted C6-C10 aryl O The number of substitution(s) may be 1 to 3 (e.g., 1), each R O The same or different;
and/or, R 33 In (1), the R P R in substituted C6-C10 aryl P The number of substitution(s) may be 1 to 3 (e.g., 1), each R P The same or different;
and/or, in the preparation of the compound shown in the formula (XIII), the usage amount of the bis-fluorosulfonyl imide is preferably 5 to 20 percent, for example 10 percent of the molar amount of the compound shown in the formula (XIII-B);
and/or, in the preparation of the compound shown in the formula (XIII), the molar ratio of the compound shown in the formula (XIII-A) to the compound shown in the formula (XIII-B) is (1-2): 1, for example 1;
and/or in the preparation of the compound shown in the formula (XIII), the molar ratio of the compound shown in the formula (XIII-C) to the compound shown in the formula (XIII-B) is (1-200): 1;
and/or in the preparation of the compound shown as the formula (XIII), the reaction is carried out in a solvent or in the absence of a solvent, wherein the solvent is one or more of a sulfoxide solvent, a ketone solvent, an alcohol solvent, an ether solvent, an ester solvent, an aromatic solvent, an amide solvent, a halogenated alkane solvent and an alkane solvent; such as one or more of tetrahydrofuran, dichloromethane, ethyl acetate, dimethyl sulfoxide, N-dimethylformamide, and 1,4-dioxane, further such as acetonitrile or dichloromethane; preferably, the reaction is carried out in the absence of a solvent;
and/or, in the preparation of the compound shown in the formula (XIII), the reaction temperature is 50-120 ℃, such as 60 ℃;
and/or, in the preparation of the compound shown in the formula (XIII), the reaction time is 1-5 hours, such as 3.5 hours.
30. The use of claim 28, wherein m is 3 Is 0 or 1, preferably m 3 Is 0;
and/or, Q is N;
and/or, R 33 C1-C6 alkyl, for example C1-C3 alkyl, and further for example methyl, ethyl, n-propyl or isopropyl.
CN202210754232.0A 2019-12-31 2019-12-31 Application of difluoro sulfimide as catalyst Active CN115141159B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210754232.0A CN115141159B (en) 2019-12-31 2019-12-31 Application of difluoro sulfimide as catalyst

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911405095.4A CN113121799B (en) 2019-12-31 2019-12-31 Application of bis (fluorosulfonyl) imide as catalyst
CN202210754232.0A CN115141159B (en) 2019-12-31 2019-12-31 Application of difluoro sulfimide as catalyst

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201911405095.4A Division CN113121799B (en) 2019-12-31 2019-12-31 Application of bis (fluorosulfonyl) imide as catalyst

Publications (2)

Publication Number Publication Date
CN115141159A true CN115141159A (en) 2022-10-04
CN115141159B CN115141159B (en) 2024-04-26

Family

ID=76768609

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202210754232.0A Active CN115141159B (en) 2019-12-31 2019-12-31 Application of difluoro sulfimide as catalyst
CN201911405095.4A Active CN113121799B (en) 2019-12-31 2019-12-31 Application of bis (fluorosulfonyl) imide as catalyst

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201911405095.4A Active CN113121799B (en) 2019-12-31 2019-12-31 Application of bis (fluorosulfonyl) imide as catalyst

Country Status (1)

Country Link
CN (2) CN115141159B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023118115A1 (en) * 2021-12-23 2023-06-29 Rhodia Operations Process for removing water from bis(fluorosulfonyl)imide solutions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036814A1 (en) * 2012-09-10 2014-03-13 江苏华盛精化工股份有限公司 Method for preparing bis(fluorosulfonyl)imide
WO2015143180A1 (en) * 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592501B (en) * 2015-01-06 2016-06-29 济南大学 A kind of preparation method of polycaprolactone
CN104530393B (en) * 2015-01-12 2016-06-08 南京工业大学 A kind of method preparing polylactone
CN105384919A (en) * 2015-12-14 2016-03-09 南京工业大学 Method for preparing polyester through catalyzing ring-opening polymerization by bis(trifluoromethylsulfonyl)imide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036814A1 (en) * 2012-09-10 2014-03-13 江苏华盛精化工股份有限公司 Method for preparing bis(fluorosulfonyl)imide
WO2015143180A1 (en) * 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ATTILA EGYED等: "The impact of binding site waters on the activity/selectivity trade-off of Janus kinase 2 (JAK2) inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 27, pages 1497 - 1508 *
GURMEET KAUR等: "Bis(fluorosulfuryl)imide: a Bronsted acid catalyst for the coupling of allylic and benzylic alcohols with allyltrimethylsilane", TETRAHEDRON LETTERS, vol. 38, no. 14, pages 2521 - 2524, XP004056750, DOI: 10.1016/S0040-4039(97)00390-0 *

Also Published As

Publication number Publication date
CN115141159B (en) 2024-04-26
CN113121799B (en) 2022-07-19
CN113121799A (en) 2021-07-16

Similar Documents

Publication Publication Date Title
EP3359522B1 (en) Process for preparation of n-boc biphenyl alaninol
WO2009140145A1 (en) Process for preparing substituted 7-cyano quinone methides
IL125841A (en) Process for preparing nitrobiphenyls
Khaligh Poly (N-vinylimidazole) as a halogen-free and efficient catalyst for N-Boc protection of amines under solvent-free conditions
US20100184978A1 (en) Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex
CN113121799B (en) Application of bis (fluorosulfonyl) imide as catalyst
CN112409317B (en) Synthesis method of cyclic carbonate and derivatives thereof
WO2014000455A1 (en) Chiral five-membered bicyclic guanidine compound, and preparation method and application thereof
CN103073421A (en) High-efficiency simple synthetic method for delta-chlorobutyl ester
JP2017071554A (en) Fluorene-based compound and method of producing fluorene-based compound
US11731940B2 (en) Process for preparing triacetonamine
IL199839A (en) Process for the manufacture of substituted 2-cyano cinnamic esters
ES2619711T3 (en) Procedure for the preparation of aminoaryl- and aminoheteroarylboronic acids and esters
JP4436754B2 (en) Method for producing phenyloxocarboxylic acid ester derivative
CN114349686A (en) 1, 4-dihydropyridine chiral hybrid hydrogenation reagent and preparation method and application thereof
JPWO2003097568A1 (en) Method for producing 4-phenyl-4-oxo-2-butenoic acid ester derivative
Zhang et al. Enantioselective fluorination of β-keto esters using a PEG-bound urea-containing chiral quaternary ammonium salt catalyst
JP3794651B2 (en) Mercapto compound, method for producing mercapto compound, tetraol compound, and method for producing tetraol compound
Kameyama et al. Synthesis of polyesters with pendant chloromethyl group by polyaddition of bis (oxetane) s with diacyl chlorides catalyzed by quaternary onium salts
CA2480239C (en) Method for manufacture of sertindole
EP3271324A1 (en) Process for the preparation of diaminobutane
JP4475901B2 (en) Method for producing 3-acetylthiophenes
JP4663105B2 (en) Method for producing 2-sulfonyl-4-oxypyridine derivative
JP2006347916A (en) Method for producing n-hydroxyethylcarbazole compound
JP2646294B2 (en) Nitrile production method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant